

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.53880237 |
| 2 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.45033203 |
| 3 | negative regulation of cell killing (GO:0031342) | 4.45033203 |
| 4 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.38198793 |
| 5 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.29245061 |
| 6 | response to peptidoglycan (GO:0032494) | 4.28258601 |
| 7 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.19133879 |
| 8 | negative regulation of interleukin-12 production (GO:0032695) | 4.12545694 |
| 9 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.07069233 |
| 10 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.04111743 |
| 11 | cellular extravasation (GO:0045123) | 4.00082771 |
| 12 | regulation of gamma-delta T cell activation (GO:0046643) | 3.91906084 |
| 13 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.81948883 |
| 14 | negative thymic T cell selection (GO:0045060) | 3.81821890 |
| 15 | negative T cell selection (GO:0043383) | 3.79512367 |
| 16 | positive thymic T cell selection (GO:0045059) | 3.74301919 |
| 17 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.71424051 |
| 18 | modulation by symbiont of host defense response (GO:0052031) | 3.69550657 |
| 19 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.69550657 |
| 20 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.69550657 |
| 21 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.69550657 |
| 22 | modulation by symbiont of host immune response (GO:0052553) | 3.69550657 |
| 23 | positive regulation by symbiont of host defense response (GO:0052509) | 3.69550657 |
| 24 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.63704996 |
| 25 | immunoglobulin mediated immune response (GO:0016064) | 3.62929180 |
| 26 | positive regulation of B cell differentiation (GO:0045579) | 3.56199135 |
| 27 | neutrophil activation involved in immune response (GO:0002283) | 3.46941501 |
| 28 | detection of other organism (GO:0098543) | 3.46401336 |
| 29 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.32107318 |
| 30 | macrophage activation involved in immune response (GO:0002281) | 3.30929077 |
| 31 | B cell receptor signaling pathway (GO:0050853) | 3.30856114 |
| 32 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.30589297 |
| 33 | T cell migration (GO:0072678) | 3.25321682 |
| 34 | positive T cell selection (GO:0043368) | 3.23127290 |
| 35 | response to muramyl dipeptide (GO:0032495) | 3.21028983 |
| 36 | detection of bacterium (GO:0016045) | 3.18427591 |
| 37 | regulation of tolerance induction (GO:0002643) | 3.17066524 |
| 38 | T cell selection (GO:0045058) | 3.16868170 |
| 39 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.16499499 |
| 40 | negative regulation of T cell mediated immunity (GO:0002710) | 3.11807788 |
| 41 | detection of molecule of bacterial origin (GO:0032490) | 3.10657694 |
| 42 | thymic T cell selection (GO:0045061) | 3.08426280 |
| 43 | regulation of T cell tolerance induction (GO:0002664) | 3.05932736 |
| 44 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.04894731 |
| 45 | regulation of B cell differentiation (GO:0045577) | 3.04575414 |
| 46 | detection of external biotic stimulus (GO:0098581) | 3.04013500 |
| 47 | B cell mediated immunity (GO:0019724) | 2.95073561 |
| 48 | pinocytosis (GO:0006907) | 2.94457917 |
| 49 | leukocyte aggregation (GO:0070486) | 2.92718571 |
| 50 | regulation of antigen processing and presentation (GO:0002577) | 2.92595082 |
| 51 | response to type I interferon (GO:0034340) | 2.86431317 |
| 52 | type I interferon signaling pathway (GO:0060337) | 2.85722051 |
| 53 | cellular response to type I interferon (GO:0071357) | 2.85722051 |
| 54 | positive regulation of antigen processing and presentation (GO:0002579) | 2.84776388 |
| 55 | response to interleukin-15 (GO:0070672) | 2.84729472 |
| 56 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.84354925 |
| 57 | defense response to protozoan (GO:0042832) | 2.82472920 |
| 58 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.82242460 |
| 59 | positive regulation of tolerance induction (GO:0002645) | 2.81158791 |
| 60 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.79022069 |
| 61 | regulation of mast cell degranulation (GO:0043304) | 2.78943292 |
| 62 | positive regulation of granulocyte differentiation (GO:0030854) | 2.78799488 |
| 63 | germinal center formation (GO:0002467) | 2.78616869 |
| 64 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.77824728 |
| 65 | response to protozoan (GO:0001562) | 2.75946747 |
| 66 | myeloid cell activation involved in immune response (GO:0002275) | 2.75886256 |
| 67 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.73951108 |
| 68 | detection of biotic stimulus (GO:0009595) | 2.73937179 |
| 69 | positive regulation of interferon-alpha production (GO:0032727) | 2.72386800 |
| 70 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.72315842 |
| 71 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.70586197 |
| 72 | response to host immune response (GO:0052572) | 2.70586197 |
| 73 | microglial cell activation (GO:0001774) | 2.69819368 |
| 74 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.69761852 |
| 75 | macrophage activation (GO:0042116) | 2.65823298 |
| 76 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.64207956 |
| 77 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.63956711 |
| 78 | response to host (GO:0075136) | 2.63754616 |
| 79 | response to host defenses (GO:0052200) | 2.63754616 |
| 80 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.63754616 |
| 81 | regulation of necroptotic process (GO:0060544) | 2.62049612 |
| 82 | mature B cell differentiation involved in immune response (GO:0002313) | 2.61529351 |
| 83 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.61351866 |
| 84 | regulation of interferon-alpha production (GO:0032647) | 2.60939050 |
| 85 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.60895458 |
| 86 | myeloid dendritic cell activation (GO:0001773) | 2.60275605 |
| 87 | regulation of leukocyte degranulation (GO:0043300) | 2.58196851 |
| 88 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.57480060 |
| 89 | respiratory burst (GO:0045730) | 2.57311781 |
| 90 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.57082538 |
| 91 | positive regulation of mast cell activation (GO:0033005) | 2.56165083 |
| 92 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.55640625 |
| 93 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.55452962 |
| 94 | positive regulation of type 2 immune response (GO:0002830) | 2.55262392 |
| 95 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.53735752 |
| 96 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.53164955 |
| 97 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.52999002 |
| 98 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.50881390 |
| 99 | positive regulation of macrophage differentiation (GO:0045651) | 2.50842130 |
| 100 | cellular response to interleukin-15 (GO:0071350) | 2.50163360 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.46445262 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.70440076 |
| 3 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.98073476 |
| 4 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.84571727 |
| 5 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.54685720 |
| 6 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.48360599 |
| 7 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.41002376 |
| 8 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.28582504 |
| 9 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.03564782 |
| 10 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.96957664 |
| 11 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.92349636 |
| 12 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.91854825 |
| 13 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.79406482 |
| 14 | MYC_22102868_ChIP-Seq_BL_Human | 2.78901440 |
| 15 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.73635069 |
| 16 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.72270865 |
| 17 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.62010045 |
| 18 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.56305714 |
| 19 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.52531580 |
| 20 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.51960757 |
| 21 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.51616675 |
| 22 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.48333905 |
| 23 | MYB_26560356_Chip-Seq_TH2_Human | 2.47680097 |
| 24 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.44678570 |
| 25 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.37429400 |
| 26 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.35161392 |
| 27 | MAF_26560356_Chip-Seq_TH1_Human | 2.27772523 |
| 28 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.23406732 |
| 29 | MYB_26560356_Chip-Seq_TH1_Human | 2.13915784 |
| 30 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.02450043 |
| 31 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.97627559 |
| 32 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.97549188 |
| 33 | SPI1_23127762_ChIP-Seq_K562_Human | 1.92738375 |
| 34 | GATA1_22025678_ChIP-Seq_K562_Human | 1.91660540 |
| 35 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.91566217 |
| 36 | UTX_26944678_Chip-Seq_JUKART_Human | 1.88324896 |
| 37 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.87397925 |
| 38 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.83806589 |
| 39 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.82093221 |
| 40 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.72580667 |
| 41 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.70110307 |
| 42 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.67534132 |
| 43 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.63435025 |
| 44 | MAF_26560356_Chip-Seq_TH2_Human | 1.61928029 |
| 45 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.60634052 |
| 46 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.56961460 |
| 47 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.56396508 |
| 48 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.53173315 |
| 49 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.52453062 |
| 50 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.51007524 |
| 51 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.50826396 |
| 52 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.50237692 |
| 53 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.45012996 |
| 54 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.42325732 |
| 55 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.40908159 |
| 56 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.36581637 |
| 57 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.35379874 |
| 58 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.31169556 |
| 59 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.30282677 |
| 60 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.27185654 |
| 61 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.26699258 |
| 62 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.25817062 |
| 63 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.25693571 |
| 64 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.23407235 |
| 65 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.22206024 |
| 66 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.21585241 |
| 67 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.21373320 |
| 68 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.19439843 |
| 69 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.19316339 |
| 70 | GATA1_19941826_ChIP-Seq_K562_Human | 1.18022422 |
| 71 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.16140606 |
| 72 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.14850821 |
| 73 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.14502813 |
| 74 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.12112860 |
| 75 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.10940489 |
| 76 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.10140242 |
| 77 | GATA3_26560356_Chip-Seq_TH2_Human | 1.08802943 |
| 78 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.01732670 |
| 79 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.00836374 |
| 80 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.00548503 |
| 81 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.97880340 |
| 82 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.97550277 |
| 83 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.97064333 |
| 84 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.94504794 |
| 85 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.94442164 |
| 86 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.93623766 |
| 87 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.93534756 |
| 88 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.93167427 |
| 89 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 0.89736139 |
| 90 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.89391434 |
| 91 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.88942410 |
| 92 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.88274821 |
| 93 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.87044904 |
| 94 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.82755965 |
| 95 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.82452342 |
| 96 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.80972434 |
| 97 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.80467051 |
| 98 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.80336292 |
| 99 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.79148269 |
| 100 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.79088742 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 3.63286469 |
| 2 | MP0003724_increased_susceptibility_to | 3.21731002 |
| 3 | MP0003303_peritoneal_inflammation | 3.18686094 |
| 4 | MP0003436_decreased_susceptibility_to | 3.17617905 |
| 5 | MP0003763_abnormal_thymus_physiology | 2.58242622 |
| 6 | MP0000685_abnormal_immune_system | 2.53139167 |
| 7 | MP0005671_abnormal_response_to | 2.50519971 |
| 8 | MP0005000_abnormal_immune_tolerance | 2.50412193 |
| 9 | MP0003300_gastrointestinal_ulcer | 2.46221674 |
| 10 | MP0001790_abnormal_immune_system | 2.44835003 |
| 11 | MP0005387_immune_system_phenotype | 2.44835003 |
| 12 | MP0002419_abnormal_innate_immunity | 2.44157884 |
| 13 | MP0001800_abnormal_humoral_immune | 2.37176826 |
| 14 | MP0005025_abnormal_response_to | 2.28165386 |
| 15 | MP0006082_CNS_inflammation | 2.22473273 |
| 16 | MP0002148_abnormal_hypersensitivity_rea | 2.21186846 |
| 17 | MP0009785_altered_susceptibility_to | 2.20749573 |
| 18 | MP0002452_abnormal_antigen_presenting | 2.16833225 |
| 19 | MP0002723_abnormal_immune_serum | 2.13126852 |
| 20 | MP0002396_abnormal_hematopoietic_system | 2.12571514 |
| 21 | MP0002420_abnormal_adaptive_immunity | 2.06612252 |
| 22 | MP0001819_abnormal_immune_cell | 2.03451459 |
| 23 | MP0002405_respiratory_system_inflammati | 1.92538224 |
| 24 | MP0009278_abnormal_bone_marrow | 1.90384663 |
| 25 | MP0005464_abnormal_platelet_physiology | 1.85869540 |
| 26 | MP0002398_abnormal_bone_marrow | 1.84183837 |
| 27 | MP0002166_altered_tumor_susceptibility | 1.81507965 |
| 28 | MP0003828_pulmonary_edema | 1.80151589 |
| 29 | MP0008438_abnormal_cutaneous_collagen | 1.77265450 |
| 30 | MP0001533_abnormal_skeleton_physiology | 1.73451763 |
| 31 | MP0009333_abnormal_splenocyte_physiolog | 1.67889107 |
| 32 | MP0003191_abnormal_cellular_cholesterol | 1.67466784 |
| 33 | MP0000716_abnormal_immune_system | 1.65080391 |
| 34 | MP0005058_abnormal_lysosome_morphology | 1.65065554 |
| 35 | MP0004947_skin_inflammation | 1.64154268 |
| 36 | MP0005397_hematopoietic_system_phenotyp | 1.63152602 |
| 37 | MP0001545_abnormal_hematopoietic_system | 1.63152602 |
| 38 | MP0010155_abnormal_intestine_physiology | 1.61430172 |
| 39 | MP0002877_abnormal_melanocyte_morpholog | 1.61245292 |
| 40 | MP0004808_abnormal_hematopoietic_stem | 1.61100621 |
| 41 | MP0002009_preneoplasia | 1.52172276 |
| 42 | MP0003172_abnormal_lysosome_physiology | 1.51356248 |
| 43 | MP0002722_abnormal_immune_system | 1.50565971 |
| 44 | MP0000689_abnormal_spleen_morphology | 1.49743781 |
| 45 | MP0001845_abnormal_inflammatory_respons | 1.48070929 |
| 46 | MP0003279_aneurysm | 1.47595656 |
| 47 | MP0000703_abnormal_thymus_morphology | 1.43613199 |
| 48 | MP0002429_abnormal_blood_cell | 1.41915368 |
| 49 | MP0001853_heart_inflammation | 1.41009375 |
| 50 | MP0000465_gastrointestinal_hemorrhage | 1.40959904 |
| 51 | MP0008057_abnormal_DNA_replication | 1.40265957 |
| 52 | MP0002998_abnormal_bone_remodeling | 1.38636778 |
| 53 | MP0001958_emphysema | 1.38049426 |
| 54 | MP0005451_abnormal_body_composition | 1.37290808 |
| 55 | MP0003705_abnormal_hypodermis_morpholog | 1.32942678 |
| 56 | MP0000858_altered_metastatic_potential | 1.27957826 |
| 57 | MP0003091_abnormal_cell_migration | 1.25542847 |
| 58 | MP0000343_altered_response_to | 1.25361375 |
| 59 | MP0002006_tumorigenesis | 1.25208885 |
| 60 | MP0003656_abnormal_erythrocyte_physiolo | 1.23638042 |
| 61 | MP0003448_altered_tumor_morphology | 1.21420758 |
| 62 | MP0010352_gastrointestinal_tract_polyps | 1.17902462 |
| 63 | MP0008004_abnormal_stomach_pH | 1.16837897 |
| 64 | MP0008469_abnormal_protein_level | 1.14816117 |
| 65 | MP0009764_decreased_sensitivity_to | 1.09256436 |
| 66 | MP0005310_abnormal_salivary_gland | 1.08914975 |
| 67 | MP0002132_abnormal_respiratory_system | 1.07967692 |
| 68 | MP0003075_altered_response_to | 1.07682221 |
| 69 | MP0001851_eye_inflammation | 1.04901261 |
| 70 | MP0005164_abnormal_response_to | 1.01042667 |
| 71 | MP0000604_amyloidosis | 1.00612843 |
| 72 | MP0005503_abnormal_tendon_morphology | 0.99767923 |
| 73 | MP0001873_stomach_inflammation | 0.96899861 |
| 74 | MP0002933_joint_inflammation | 0.96459489 |
| 75 | MP0005166_decreased_susceptibility_to | 0.95966139 |
| 76 | MP0003866_abnormal_defecation | 0.95344412 |
| 77 | MP0005390_skeleton_phenotype | 0.94954672 |
| 78 | MP0008260_abnormal_autophagy | 0.93771467 |
| 79 | MP0004883_abnormal_blood_vessel | 0.91814511 |
| 80 | MP0009763_increased_sensitivity_to | 0.90591898 |
| 81 | MP0003045_fibrosis | 0.87006464 |
| 82 | MP0006054_spinal_hemorrhage | 0.86315110 |
| 83 | MP0001542_abnormal_bone_strength | 0.82925711 |
| 84 | MP0005275_abnormal_skin_tensile | 0.82912821 |
| 85 | MP0000249_abnormal_blood_vessel | 0.82645598 |
| 86 | MP0005076_abnormal_cell_differentiation | 0.81123867 |
| 87 | MP0005023_abnormal_wound_healing | 0.80773671 |
| 88 | MP0002019_abnormal_tumor_incidence | 0.80094904 |
| 89 | MP0003795_abnormal_bone_structure | 0.76439908 |
| 90 | MP0010307_abnormal_tumor_latency | 0.73470497 |
| 91 | MP0000490_abnormal_crypts_of | 0.72336869 |
| 92 | MP0004185_abnormal_adipocyte_glucose | 0.71790722 |
| 93 | MP0003690_abnormal_glial_cell | 0.70132997 |
| 94 | MP0003566_abnormal_cell_adhesion | 0.69763165 |
| 95 | MP0000767_abnormal_smooth_muscle | 0.69033275 |
| 96 | MP0000015_abnormal_ear_pigmentation | 0.68024374 |
| 97 | MP0005165_increased_susceptibility_to | 0.67354866 |
| 98 | MP0003950_abnormal_plasma_membrane | 0.66803488 |
| 99 | MP0000681_abnormal_thyroid_gland | 0.66441544 |
| 100 | MP0010368_abnormal_lymphatic_system | 0.66254857 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 4.56649079 |
| 2 | Recurrent abscess formation (HP:0002722) | 4.47623455 |
| 3 | Recurrent bacterial skin infections (HP:0005406) | 4.39459658 |
| 4 | T lymphocytopenia (HP:0005403) | 3.93756894 |
| 5 | Recurrent viral infections (HP:0004429) | 3.87208635 |
| 6 | Spontaneous hematomas (HP:0007420) | 3.71392449 |
| 7 | Recurrent fungal infections (HP:0002841) | 3.67525574 |
| 8 | Abnormality of T cell number (HP:0011839) | 3.66844204 |
| 9 | Myositis (HP:0100614) | 3.59399305 |
| 10 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.54645885 |
| 11 | Abnormality of macrophages (HP:0004311) | 3.51359253 |
| 12 | Stomatitis (HP:0010280) | 3.39333478 |
| 13 | Panhypogammaglobulinemia (HP:0003139) | 3.36484073 |
| 14 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.26091714 |
| 15 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.26091714 |
| 16 | Abnormality of glycolipid metabolism (HP:0010969) | 3.26091714 |
| 17 | Meningitis (HP:0001287) | 3.22003611 |
| 18 | Mediastinal lymphadenopathy (HP:0100721) | 3.13356275 |
| 19 | Cellulitis (HP:0100658) | 3.12852014 |
| 20 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.11984466 |
| 21 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.07647765 |
| 22 | Recurrent skin infections (HP:0001581) | 3.00348983 |
| 23 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.99447536 |
| 24 | Recurrent cutaneous fungal infections (HP:0011370) | 2.99447536 |
| 25 | Orchitis (HP:0100796) | 2.98936941 |
| 26 | Abnormality of T cells (HP:0002843) | 2.98213791 |
| 27 | Agammaglobulinemia (HP:0004432) | 2.95870481 |
| 28 | Autoimmune thrombocytopenia (HP:0001973) | 2.92482551 |
| 29 | Obstructive lung disease (HP:0006536) | 2.90738273 |
| 30 | Chronic obstructive pulmonary disease (HP:0006510) | 2.90738273 |
| 31 | Gingivitis (HP:0000230) | 2.86748069 |
| 32 | Granulocytopenia (HP:0001913) | 2.77559590 |
| 33 | Retrobulbar optic neuritis (HP:0100654) | 2.76150945 |
| 34 | Optic neuritis (HP:0100653) | 2.76150945 |
| 35 | Interstitial pulmonary disease (HP:0006530) | 2.75146078 |
| 36 | Abnormality of B cell number (HP:0010975) | 2.71364953 |
| 37 | B lymphocytopenia (HP:0010976) | 2.71114303 |
| 38 | Autoimmune hemolytic anemia (HP:0001890) | 2.70064862 |
| 39 | Increased cerebral lipofuscin (HP:0011813) | 2.66934048 |
| 40 | Gastrointestinal infarctions (HP:0005244) | 2.66192429 |
| 41 | Spondylolisthesis (HP:0003302) | 2.62028762 |
| 42 | Vasculitis (HP:0002633) | 2.58681520 |
| 43 | Abnormality of T cell physiology (HP:0011840) | 2.58306147 |
| 44 | Leukocytosis (HP:0001974) | 2.54426621 |
| 45 | Eosinophilia (HP:0001880) | 2.50626963 |
| 46 | Pulmonary infiltrates (HP:0002113) | 2.46803544 |
| 47 | Colitis (HP:0002583) | 2.45794539 |
| 48 | Severe combined immunodeficiency (HP:0004430) | 2.45064340 |
| 49 | Prolonged bleeding time (HP:0003010) | 2.41828694 |
| 50 | Recurrent bronchitis (HP:0002837) | 2.40626400 |
| 51 | Combined immunodeficiency (HP:0005387) | 2.39904433 |
| 52 | Increased IgE level (HP:0003212) | 2.38260647 |
| 53 | Chest pain (HP:0100749) | 2.38046211 |
| 54 | Hemoptysis (HP:0002105) | 2.35959751 |
| 55 | Epistaxis (HP:0000421) | 2.35379949 |
| 56 | Thrombocytosis (HP:0001894) | 2.35222463 |
| 57 | Dysostosis multiplex (HP:0000943) | 2.32929639 |
| 58 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.32197389 |
| 59 | Encephalitis (HP:0002383) | 2.30227174 |
| 60 | Osteomyelitis (HP:0002754) | 2.30035185 |
| 61 | Keratoconjunctivitis sicca (HP:0001097) | 2.30023563 |
| 62 | Inflammation of the large intestine (HP:0002037) | 2.25884578 |
| 63 | Loss of speech (HP:0002371) | 2.23746147 |
| 64 | Gastrointestinal inflammation (HP:0004386) | 2.23251984 |
| 65 | Fatigue (HP:0012378) | 2.20922434 |
| 66 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.20503967 |
| 67 | Hypergammaglobulinemia (HP:0010702) | 2.19644976 |
| 68 | Abnormality of the prostate (HP:0008775) | 2.18714817 |
| 69 | Prostate neoplasm (HP:0100787) | 2.18444447 |
| 70 | Increased IgM level (HP:0003496) | 2.14996718 |
| 71 | Arterial thrombosis (HP:0004420) | 2.11640449 |
| 72 | Systemic lupus erythematosus (HP:0002725) | 2.10793177 |
| 73 | Vacuolated lymphocytes (HP:0001922) | 2.10169093 |
| 74 | Urticaria (HP:0001025) | 2.09900066 |
| 75 | Peritonitis (HP:0002586) | 2.07025803 |
| 76 | Abnormality of the peritoneum (HP:0002585) | 2.05459883 |
| 77 | Viral hepatitis (HP:0006562) | 2.04796844 |
| 78 | Keratoconjunctivitis (HP:0001096) | 2.04771931 |
| 79 | Conjunctival telangiectasia (HP:0000524) | 2.03694097 |
| 80 | Hematochezia (HP:0002573) | 1.99609631 |
| 81 | Abnormality of the fingertips (HP:0001211) | 1.97067203 |
| 82 | Hypoplasia of the thymus (HP:0000778) | 1.95922496 |
| 83 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.95278362 |
| 84 | Osteolytic defects of the hand bones (HP:0009699) | 1.95278362 |
| 85 | Abnormality of eosinophils (HP:0001879) | 1.94663437 |
| 86 | Polycythemia (HP:0001901) | 1.94568521 |
| 87 | Dilatation of the ascending aorta (HP:0005111) | 1.93504067 |
| 88 | Myocardial infarction (HP:0001658) | 1.93464158 |
| 89 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.93366243 |
| 90 | Glomerulopathy (HP:0100820) | 1.93147364 |
| 91 | Recurrent lower respiratory tract infections (HP:0002783) | 1.91524955 |
| 92 | Spinal cord lesions (HP:0100561) | 1.89071965 |
| 93 | Syringomyelia (HP:0003396) | 1.89071965 |
| 94 | Protrusio acetabuli (HP:0003179) | 1.88566795 |
| 95 | Purpura (HP:0000979) | 1.88181815 |
| 96 | Aortic aneurysm (HP:0004942) | 1.87612291 |
| 97 | Sepsis (HP:0100806) | 1.86818545 |
| 98 | Gingival bleeding (HP:0000225) | 1.84773592 |
| 99 | IgG deficiency (HP:0004315) | 1.84162560 |
| 100 | Chronic diarrhea (HP:0002028) | 1.83234845 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K14 | 2.86449884 |
| 2 | RIPK4 | 2.83932104 |
| 3 | TYK2 | 2.77266483 |
| 4 | MAP4K1 | 2.76806696 |
| 5 | MAP3K13 | 2.71303783 |
| 6 | PRPF4B | 2.65098298 |
| 7 | MAP2K3 | 2.46841264 |
| 8 | ERN1 | 2.40528811 |
| 9 | TRIB3 | 2.29556512 |
| 10 | BLK | 2.28411748 |
| 11 | TESK2 | 2.22728115 |
| 12 | ZAP70 | 2.13290360 |
| 13 | FES | 2.09684521 |
| 14 | CDK12 | 1.99569019 |
| 15 | JAK3 | 1.89347135 |
| 16 | KIT | 1.87391410 |
| 17 | JAK1 | 1.86710462 |
| 18 | CSK | 1.81827485 |
| 19 | SMG1 | 1.77438649 |
| 20 | IRAK4 | 1.69800263 |
| 21 | TEC | 1.68395167 |
| 22 | TGFBR2 | 1.68306176 |
| 23 | TBK1 | 1.65323596 |
| 24 | TXK | 1.64844875 |
| 25 | IRAK3 | 1.64810551 |
| 26 | BTK | 1.64158894 |
| 27 | SYK | 1.54384180 |
| 28 | IKBKE | 1.46249802 |
| 29 | ITK | 1.43608883 |
| 30 | CAMKK2 | 1.39283844 |
| 31 | NEK9 | 1.33609563 |
| 32 | GRK6 | 1.32884855 |
| 33 | TRPM7 | 1.32171924 |
| 34 | HCK | 1.25584586 |
| 35 | MAP3K3 | 1.25395568 |
| 36 | EEF2K | 1.24107689 |
| 37 | SCYL2 | 1.23029736 |
| 38 | TAOK3 | 1.22280091 |
| 39 | STK10 | 1.17936602 |
| 40 | CDK6 | 1.17701216 |
| 41 | LYN | 1.14203842 |
| 42 | TTN | 1.12782696 |
| 43 | CSF1R | 1.10063430 |
| 44 | IKBKB | 1.08041589 |
| 45 | JAK2 | 1.06199912 |
| 46 | CDK4 | 1.06074752 |
| 47 | PIK3CG | 1.05657139 |
| 48 | LCK | 1.05168591 |
| 49 | GRK7 | 0.89785801 |
| 50 | MOS | 0.89718029 |
| 51 | MAPK11 | 0.88966856 |
| 52 | BMPR2 | 0.88363675 |
| 53 | KDR | 0.84339468 |
| 54 | KSR2 | 0.83516011 |
| 55 | CDC42BPA | 0.82154727 |
| 56 | HIPK2 | 0.81139367 |
| 57 | MAP3K1 | 0.76703652 |
| 58 | LRRK2 | 0.75482442 |
| 59 | MAPK7 | 0.74110581 |
| 60 | RPS6KC1 | 0.72575756 |
| 61 | RPS6KL1 | 0.72575756 |
| 62 | CAMK1D | 0.70669800 |
| 63 | TAOK2 | 0.70244987 |
| 64 | PDK1 | 0.69562502 |
| 65 | PDPK1 | 0.69521989 |
| 66 | MAP3K7 | 0.67503062 |
| 67 | CAMKK1 | 0.67337118 |
| 68 | IRAK1 | 0.66145693 |
| 69 | MELK | 0.65948074 |
| 70 | MAP3K6 | 0.65372972 |
| 71 | FGFR3 | 0.64178606 |
| 72 | MAP3K11 | 0.63408822 |
| 73 | MARK3 | 0.63169856 |
| 74 | PIM1 | 0.61952033 |
| 75 | TNK2 | 0.59735197 |
| 76 | NME2 | 0.59590689 |
| 77 | MAPK12 | 0.59491129 |
| 78 | FGFR4 | 0.57520228 |
| 79 | RPS6KA6 | 0.55924353 |
| 80 | FGR | 0.54165014 |
| 81 | CLK1 | 0.53411147 |
| 82 | PDGFRA | 0.51132961 |
| 83 | MARK2 | 0.50767006 |
| 84 | BRD4 | 0.50544357 |
| 85 | CAMK1G | 0.48479867 |
| 86 | NLK | 0.48423674 |
| 87 | PDGFRB | 0.48218900 |
| 88 | RAF1 | 0.47817315 |
| 89 | EPHB1 | 0.46001073 |
| 90 | MAP3K8 | 0.44448717 |
| 91 | MATK | 0.43999812 |
| 92 | MAPK4 | 0.41349639 |
| 93 | RIPK1 | 0.40865492 |
| 94 | MAPKAPK2 | 0.39139814 |
| 95 | SIK3 | 0.39134622 |
| 96 | RPS6KA2 | 0.38595313 |
| 97 | PKN2 | 0.38566866 |
| 98 | CDK9 | 0.38135813 |
| 99 | PRKCQ | 0.36693834 |
| 100 | ICK | 0.34059366 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Leishmaniasis_Homo sapiens_hsa05140 | 2.63912135 |
| 2 | Allograft rejection_Homo sapiens_hsa05330 | 2.55109582 |
| 3 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.51619154 |
| 4 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.38190408 |
| 5 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.33910034 |
| 6 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.33420944 |
| 7 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.32030600 |
| 8 | Asthma_Homo sapiens_hsa05310 | 2.22738503 |
| 9 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.14763501 |
| 10 | Other glycan degradation_Homo sapiens_hsa00511 | 2.13519777 |
| 11 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.99492354 |
| 12 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.95304173 |
| 13 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.92196494 |
| 14 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.91548256 |
| 15 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.83914161 |
| 16 | Measles_Homo sapiens_hsa05162 | 1.82485619 |
| 17 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.82288769 |
| 18 | Tuberculosis_Homo sapiens_hsa05152 | 1.80555886 |
| 19 | Malaria_Homo sapiens_hsa05144 | 1.75138714 |
| 20 | Viral myocarditis_Homo sapiens_hsa05416 | 1.73948688 |
| 21 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.65178404 |
| 22 | Influenza A_Homo sapiens_hsa05164 | 1.64931800 |
| 23 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.64778611 |
| 24 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.63406083 |
| 25 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.60523070 |
| 26 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.60234251 |
| 27 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.56319930 |
| 28 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.55301267 |
| 29 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.54803780 |
| 30 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.51898663 |
| 31 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.46125814 |
| 32 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.37395612 |
| 33 | Hepatitis B_Homo sapiens_hsa05161 | 1.37253832 |
| 34 | Pertussis_Homo sapiens_hsa05133 | 1.36791049 |
| 35 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.36248860 |
| 36 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.35867795 |
| 37 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.35077685 |
| 38 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.34410648 |
| 39 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.33499881 |
| 40 | Lysosome_Homo sapiens_hsa04142 | 1.32504601 |
| 41 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.30403620 |
| 42 | Legionellosis_Homo sapiens_hsa05134 | 1.28229340 |
| 43 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.24476674 |
| 44 | Platelet activation_Homo sapiens_hsa04611 | 1.20803635 |
| 45 | Phagosome_Homo sapiens_hsa04145 | 1.18804730 |
| 46 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.18255404 |
| 47 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.16223543 |
| 48 | Apoptosis_Homo sapiens_hsa04210 | 1.12324827 |
| 49 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.10910274 |
| 50 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.06562324 |
| 51 | HTLV-I infection_Homo sapiens_hsa05166 | 0.98415467 |
| 52 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.95461491 |
| 53 | Hepatitis C_Homo sapiens_hsa05160 | 0.94690004 |
| 54 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.92264865 |
| 55 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.91622329 |
| 56 | Salmonella infection_Homo sapiens_hsa05132 | 0.90000825 |
| 57 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.87838342 |
| 58 | Shigellosis_Homo sapiens_hsa05131 | 0.87737299 |
| 59 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.85917551 |
| 60 | Bladder cancer_Homo sapiens_hsa05219 | 0.82999116 |
| 61 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.81076525 |
| 62 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.80175733 |
| 63 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.79993703 |
| 64 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.78913202 |
| 65 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.77162914 |
| 66 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.73985534 |
| 67 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.73923331 |
| 68 | Amoebiasis_Homo sapiens_hsa05146 | 0.73252822 |
| 69 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.71242813 |
| 70 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.64076266 |
| 71 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.63327938 |
| 72 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.59967647 |
| 73 | DNA replication_Homo sapiens_hsa03030 | 0.59815628 |
| 74 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.57661790 |
| 75 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.54045699 |
| 76 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.53792813 |
| 77 | Prostate cancer_Homo sapiens_hsa05215 | 0.53462053 |
| 78 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.49818608 |
| 79 | Colorectal cancer_Homo sapiens_hsa05210 | 0.45286136 |
| 80 | Glioma_Homo sapiens_hsa05214 | 0.44685796 |
| 81 | Prion diseases_Homo sapiens_hsa05020 | 0.42097153 |
| 82 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.41555975 |
| 83 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.41277067 |
| 84 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.41021726 |
| 85 | Endocytosis_Homo sapiens_hsa04144 | 0.40103176 |
| 86 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.40032455 |
| 87 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.39738821 |
| 88 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.37381263 |
| 89 | Focal adhesion_Homo sapiens_hsa04510 | 0.36756326 |
| 90 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.36560526 |
| 91 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.36230794 |
| 92 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.35687821 |
| 93 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.34640564 |
| 94 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.34206115 |
| 95 | Insulin resistance_Homo sapiens_hsa04931 | 0.34085011 |
| 96 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.32537964 |
| 97 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.30501951 |
| 98 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.29603617 |
| 99 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.29072010 |
| 100 | Endometrial cancer_Homo sapiens_hsa05213 | 0.28520336 |

